 SAN DIEGO, April 05, 2021 GLOBE NEWSWIRE -- Metacrine, Inc. NASDAQ:MTCR, a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal diseases, today announced the appointment of Julia C. Owens, Ph.D. to the Companys board of directors, effective April 1, 2021. Dr. Owens will serve as a member of the Compensation Committee. 